Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DNTH compared with CGON: revenue, margins and what each company keeps, and the suppliers and customers both name
DNTH
Dianthus Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
CGON
CG Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DNTH
Dianthus Therapeutics, Inc.
vs
CGON
CG Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
DNTH, solid
CGON, dashed
DNTH
Dianthus Therapeutics, Inc.
Change
82.06
▼
−0.38%
Mkt cap
$4.6B
Revenue
$761,000
Q2 FY26
Revenue
$6M
FY24
CGON
CG Oncology, Inc.
Change
62.12
▼
−3.96%
Regular session
Sep 2 '83
Mkt cap
$5.7B
Revenue
$1M
Q2 FY26
Revenue
—
vs
Compare
Regular session
Sep 2 '83
DNTH
Dianthus Therapeutics, Inc.
vs
CGON
CG Oncology, Inc.
82.06
▼
−0.38%
Price
62.12
▼
−3.96%
$4.6B
Mkt cap
$5.7B
Q2 FY26
$761,000
Revenue
$1M
Q2 FY26
FY24
$6M
Revenue
—
Change
Change
DNTH
82.06
▼
−0.38%
vs
CGON
62.12
▼
−3.96%
Regular session
Sep 2 '83